General Electric Co. v. Raytheon Technologies Corporation, fka United Technologies Corporation, Case No. 19-1012.
On February 24, 2020, we reported on GE’s petition for certiorari to the Supreme Court....more
Grit Energy Solutions, LLC v. Oren Technologies, LLC, Appeal No. 2019-1063 (Fed. Cir.. April 30, 2020).
Grit Energy filed a petition for inter partes review against Oren’s U.S. Patent No. 8,585,341 pertaining to systems of...more
Argentum Pharmaceuticals LLC v. Novartis Pharmaceuticals Corp., Appeal No. 2018-2273 (Fed. Cir., April 23, 2020).
Argentum and other petitioners filed IPRs against Novartis’ patent related to methods of treating...more
5/1/2020
/ Abbreviated New Drug Application (ANDA) ,
Article III ,
Injury-in-Fact ,
Inter Partes Review (IPR) Proceeding ,
Life Sciences ,
Novartis ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Standing
General Electric v. United Technologies Corp.
General Electric petitioned for an IPR against a United Technologies patent relating to gas turbine engines. General Electric was unsuccessful against certain claims, and...more
GoPro, Inc. v. 360Heros, Inc., IPR2018-01754 (Precedential Opinion Panel, August 23, 2019) -
Section 315(b) of Title 35 prohibits institution of an IPR where the petition is filed more than one year after service of a...more
The Federal Circuit just issued a decision that confirms its stance on Article III standing for appeals from inter partes reviews (IPRs), making it tougher for unsuccessful IPR petitioners to obtain judicial review of U.S....more
2/8/2019
/ Appeals ,
Article III ,
Biosimilars ,
Bristol-Myers Squibb ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Momenta ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Standing ,
USPTO